Health-related quality of life during and after stem cell transplantation

Autor: Frödin, Ulla

Hematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of malignant diseases, as well as a small proportion of non-malignant disorders. The treatment before the HSCT (called conditioning) can be either myeloablative

Externí odkaz: http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-92806

Adjusted conditioning for allogeneic transplantation in a single center setting: mixed chimerism heralds relapse.

Autor: Juliusson G; Department of Hematology and Blood Bank Service, University Hospital Linking, Institution for Biomedicine and Surgery, Faculty of Health Sciences, University of Linköping, SE-58185 Linköping, Sweden. gunnar.juliusson@lio.se, Karlsson K, Malm C, Frödin U, Mollén AS, Bäckström G, Söderkvist P

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2003 Apr; Vol. 44 (4), pp. 669-79.